German Biotech Raises Record $270M Series A for Individualized Cancer Therapies
BioNTech will dedicate its huge fundraising to develop personalized cancer immunotherapies using CAR-T, TCR and…
BioNTech will dedicate its huge fundraising to develop personalized cancer immunotherapies using CAR-T, TCR and…
Moderna Therapeutics has started dosing patients with an mRNA-based personalized cancer vaccine that resembles another…
An interview never seen before. We brought together the founders and CEOs of the two…
AstraZeneca will work with Moderna Therapeutics to bring together to the market an mRNA version of Novartis' failed…
CureVac will be working with pharma giant Eli Lilly in the development of up to…
Biotech is the best source of innovation in R&D, making its companies the darlings of…
Flanders Innovation and Entrepreneurship has given eTheRNA a €1M grant to further improve its TriMix…
You’ve certainly heard about antibodies, peptides and even DNA as therapeutics, but what about RNA?…
AstraZeneca and its R&D arm MedImmune have partnered with Munich-based Ethris to use its mRNA…
CureVac has published proof-of-concept data for an mRNA rabies vaccine that could open the door…
BioNTech has published results from the first clinical trial for an mRNA-based individualized vaccine with…
Sean Marett took a red-eye from New York to speak at Refresh last month: here…